KUROS
LIVE

Serial Number

79246244

Owner

Kuros Biosurgery AG

Attorney

Jody H. Drake

Filing Date

Aug 10, 2018

Add to watchlist:

No watchlists yet
View on USPTO

KUROS Trademark

Serial Number: 79246244 • Registration: 6155634

KUROS is a trademark filed by Kuros Biosurgery AG on August 10, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Kuros Biosurgery AG (8 trademarks)

Wagistrasse 25

Entity Type: 99

Trademark Details

Filing Date

August 10, 2018

Registration Date

September 22, 2020

Published for Opposition

July 7, 2020

Goods & Services

Medical product training for doctors and medical personnel

Pharmaceutical substances and preparations in the nature of protein and peptide preparations, in particular for the formation or regeneration of missing or damaged body parts, specifically, parts of the musculoskeletal system, in particular bones; goods of synthetic and natural origin for medical use, in particular consisting of fibrin and polyethylene glycol, for the retention or the delayed release of peptides or proteins, specifically growth factors and hormones which are the substances which stimulate the growth of an organism or maintain it, namely, growth factors and hormones; biomedical and biotechnology products for medical use, namely, orthobiologics that are substances which stimulate the growth or maintenance of musculoskeletal tissues in the nature of growth factors and hormones; orthobiologics for medical use for the permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous musculoskeletal tissues, in particular for bones, intervertebral discs, cartilage, fat and muscle tissues, namely, orthobiologics in the nature of synthetic matrices, growth factors and hormones; permanent and temporary medical adhesives for binding internal tissue compatible with the body, in particular for human or animal organs, soft tissues, and hard tissues for medical use; separation products for medical use compatible with the body, intended to prevent organs and soft parts from sticking together, namely, anti-adhesion products in the nature of anti-adhesion gels for use during and following surgery; modified implants comprising living tissue in endogenous material, tissues, cells and molecules for replacing and assisting the function of missing or damaged body parts; biological endogenous soft tissue, grafts in particular for fat tissue and tissue replacement; biological endogenous hard and soft tissue, grafts in particular for bones for transplantation purposes; natural biomaterials for bone, cartilage, vessel, tissue and fat tissue replacement, namely, biological tissue grafts

Medical services provided by a doctor; providing medical advice in the field of orthobiologics, adhesive barriers and tissue sealants

Synthetic biomaterials for the substitution of tissue, for the recovery, maintenance and the repair of the function of diseased or damaged human or animal tissue for medical purposes; surgical synthetic implants and modified surgical implants for replacing and assisting with the function of missing or damaged body parts, all comprising artificial material; synthetic hard and soft prosthetic tissues, in particular synthetic bone substitution for surgical use in the nature of being for transplantation and diagnostic purposes and for bone, vessel, tissue and fat tissue substitution; modified surgical implants for replacing and assisting with the function of missing or damaged body parts, all comprising artificial material

Research and development in the field of biomedicine and biomaterials; engineering services provided by a pharmaceutical or biotechnological company, in particular by a pharmacologist, a biochemist, a scientist specialized in biomaterials or a biotechnologist in the field of tissue engineering; scientific research services for medical use

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 22, 2025 REM3
INTERNATIONAL REGISTRATION RENEWED
Oct 13, 2022 RNWL
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 30, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 11, 2021 FICS
FINAL DISPOSITION PROCESSED
Jan 11, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 22, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 22, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Jul 10, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 7, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 17, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 17, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 13, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 13, 2020 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 8, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 22, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 22, 2020 OPNR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Nov 18, 2019 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Nov 18, 2019 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Nov 18, 2019 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 30, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 30, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 30, 2019 ERFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2019 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 12, 2019 TCCA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 2, 2019 GNFN
FINAL REFUSAL E-MAILED
May 2, 2019 GNFR
FINAL REFUSAL WRITTEN
May 2, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 11, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 11, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 11, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 20, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 20, 2019 REAP
REFUSAL PROCESSED BY IB
Jan 5, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 15, 2018 RFCS
REFUSAL PROCESSED BY MPU
Dec 15, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 7, 2018 RFCR
NON-FINAL ACTION WRITTEN
Dec 6, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 30, 2018 MAFR
ASSIGNED TO EXAMINER
Nov 28, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 26, 2018 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Nov 22, 2018 SDRC